These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27482422)

  • 21. HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay.
    Sunshine S; Kirchner R; Amr SS; Mansur L; Shakhbatyan R; Kim M; Bosque A; Siliciano RF; Planelles V; Hofmann O; Ho Sui S; Li JZ
    J Virol; 2016 May; 90(9):4511-4519. PubMed ID: 26912621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.
    Lorenzi JC; Cohen YZ; Cohn LB; Kreider EF; Barton JP; Learn GH; Oliveira T; Lavine CL; Horwitz JA; Settler A; Jankovic M; Seaman MS; Chakraborty AK; Hahn BH; Caskey M; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):E7908-E7916. PubMed ID: 27872306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children.
    Luzuriaga K
    Annu Rev Med; 2016; 67():201-13. PubMed ID: 26768239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV evolution and diversity in ART-treated patients.
    van Zyl G; Bale MJ; Kearney MF
    Retrovirology; 2018 Jan; 15(1):14. PubMed ID: 29378595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious Virus Persists in CD4
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood CXCR3
    Banga R; Procopio FA; Ruggiero A; Noto A; Ohmiti K; Cavassini M; Corpataux JM; Paxton WA; Pollakis G; Perreau M
    Front Immunol; 2018; 9():144. PubMed ID: 29459864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Origins of Virus Persistence during Natural Control of HIV Infection.
    Boritz EA; Darko S; Swaszek L; Wolf G; Wells D; Wu X; Henry AR; Laboune F; Hu J; Ambrozak D; Hughes MS; Hoh R; Casazza JP; Vostal A; Bunis D; Nganou-Makamdop K; Lee JS; Migueles SA; Koup RA; Connors M; Moir S; Schacker T; Maldarelli F; Hughes SH; Deeks SG; Douek DC
    Cell; 2016 Aug; 166(4):1004-1015. PubMed ID: 27453467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in HIV reservoirs during long-term antiretroviral therapy.
    Hong FF; Mellors JW
    Curr Opin HIV AIDS; 2015 Jan; 10(1):43-8. PubMed ID: 25402706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV rebounds from latently infected cells, rather than from continuing low-level replication.
    Joos B; Fischer M; Kuster H; Pillai SK; Wong JK; Böni J; Hirschel B; Weber R; Trkola A; Günthard HF;
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16725-30. PubMed ID: 18936487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.
    Veenhuis RT; Kwaa AK; Garliss CC; Latanich R; Salgado M; Pohlmeyer CW; Nobles CL; Gregg J; Scully EP; Bailey JR; Bushman FD; Blankson JN
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral and latent reservoir persistence in HIV-1-infected patients on therapy.
    Kim H; Perelson AS
    PLoS Comput Biol; 2006 Oct; 2(10):e135. PubMed ID: 17040122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.